Reaction
Placental Insufficiency reporting signals
As of the last recalculation, Placental Insufficiency appears in 797 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ATAZANAVIR (PRR 52.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Atazanavir | 28 | 52.7 | 52.8 |
| Tenofovir Disoproxil Fumarate Tablets | 16 | 49.4 | 49.5 |
| Misoprostol | 16 | 43.8 | 43.8 |
| Lopinavir And Ritonavir | 21 | 41.5 | 41.6 |
| Nevirapine | 13 | 38.2 | 38.3 |
| Dalteparin Sodium | 13 | 32.6 | 32.6 |
| Labetalol | 16 | 32.0 | 32.0 |
| Ritonavir | 29 | 26.9 | 26.9 |
| Tenofovir Disoproxil Fumarate | 29 | 23.7 | 23.8 |
| Zidovudine | 10 | 19.8 | 19.8 |
| Pyrazinamide | 6 | 16.8 | 16.8 |